FDA Will Rev GMP Inspections Of Medium Supplement Firms, After A Pause
This article was originally published in The Tan Sheet
Executive Summary
Medium-sized dietary supplement firms should not be fooled if FDA gets off to a slow start inspecting for good manufacturing practices compliance, but should expect a marked uptick in the agency's volume of inspections
You may also be interested in...
First GMP Warning Letter Reflects FDA's List Of Major Concerns
FDA's first warning letter concerning dietary supplement good manufacturing practices advises Coats International Holdings to follow written procedures, improve documentation and conduct appropriate identity tests
First GMP Warning Letter Reflects FDA's List Of Major Concerns
FDA's first warning letter concerning dietary supplement good manufacturing practices advises Coats International Holdings to follow written procedures, improve documentation and conduct appropriate identity tests
First GMP Warning Letter Reflects FDA's List Of Major Concerns
FDA's first warning letter concerning dietary supplement good manufacturing practices advises Coats International Holdings to follow written procedures, improve documentation and conduct appropriate identity tests